Literature DB >> 17989171

Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Jangsuk Oh1, Mary Jane McWilliams, John G Julias, Stephen H Hughes.   

Abstract

In retroviruses, the first nucleotide added to the tRNA primer defines the end of the U5 region in the right long terminal repeat, and the subsequent removal of this tRNA primer by RNase H exactly defines the U5 end of the linear double-stranded DNA. In most retroviruses, the entire tRNA is removed by RNase H cleavage at the RNA/DNA junction. However, the RNase H domain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase cleaves the tRNA 1 nucleotide from the RNA/DNA junction at the U5/primer binding site (PBS) junction, which leaves an rA residue at the U5 terminus. We made sequence changes at the end of the U5 region adjacent to the PBS in HIV-1 to determine whether such changes affect the specificity of tRNA primer cleavage by RNase H. In some of the mutants, RNase H usually removed the entire tRNA, showing that the cleavage specificity was shifted by 1 nucleotide. This result suggests that the tRNA cleavage specificity of the HIV-1 RNase domain H depends on sequences in U5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989171      PMCID: PMC2224596          DOI: 10.1128/JVI.02611-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The sequence of human immunodeficiency virus type 2 circle junction suggests that integration protein cleaves the ends of linear DNA asymmetrically.

Authors:  J M Whitcomb; S H Hughes
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 3.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

4.  Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.

Authors:  B M Wöhrl; K Moelling
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

5.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3).

Authors:  J S Smith; M J Roth
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

8.  Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  K A Pullen; L K Ishimoto; J J Champoux
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.

Authors:  V Gopalakrishnan; J A Peliska; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.

Authors:  P L Boyer; A L Ferris; P Clark; J Whitmer; P Frank; C Tantillo; E Arnold; S H Hughes
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

View more
  12 in total

1.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  4'-C-methyl-2'-deoxyadenosine and 4'-C-ethyl-2'-deoxyadenosine inhibit HIV-1 replication.

Authors:  B Christie Vu; Paul L Boyer; Maqbool A Siddiqui; Victor E Marquez; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.

Authors:  Paul L Boyer; Steven J Smith; Xue Zhi Zhao; Kalyan Das; Kevin Gruber; Eddy Arnold; Terrence R Burke; Stephen H Hughes
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

4.  Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.

Authors:  Janani Varadarajan; Mary Jane McWilliams; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

5.  HIV-1 integrase strand transfer inhibitors stabilize an integrase-single blunt-ended DNA complex.

Authors:  Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Duane P Grandgenett
Journal:  J Mol Biol       Date:  2011-02-03       Impact factor: 5.469

6.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  North- and south-bicyclo[3.1.0]hexene nucleosides: the effect of ring planarity on anti-HIV activity.

Authors:  Pamela L Russ; Maria J Gonzalez-Moa; B Christie Vu; Dina M Sigano; James A Kelley; Christopher C Lai; Jeffrey R Deschamps; Stephen H Hughes; Victor E Marquez
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

8.  The nucleoside analogue D-carba T blocks HIV-1 reverse transcription.

Authors:  Paul L Boyer; B Christie Vu; Zandrea Ambrose; John G Julias; Svenja Warnecke; Chenzhong Liao; Chris Meier; Victor E Marquez; Stephen H Hughes
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

9.  Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Sanggu Kim; Namshin Kim; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.

Authors:  Greg L Beilhartz; Matthias Götte
Journal:  Viruses       Date:  2010-03-30       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.